NR3C2 and hydrops fetalis: With regard to HF therapy, neurohumoral-directed approaches, such as beta blockers, RAAS and angiotensin-converting enzyme (ACE) inhibitors and/or mineralocorticoid receptor antagonists (MRAs), and more recently, AVP antagonists seem to be a more logical approach with proven benefits.